Non-alcoholic fatty liver disease: A review with clinical and pathological correlation

被引:26
|
作者
Chen, Yen-Ying [1 ,2 ]
Yeh, Matthew M. [3 ,4 ]
机构
[1] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan
[3] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA
[4] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
关键词
Fatty liver; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; GLOBAL EPIDEMIOLOGY; STEATOHEPATITIS; PREVALENCE; FIBROSIS; NAFLD; METAANALYSIS; ASSOCIATION; DIAGNOSIS; STEATOSIS; ALGORITHM;
D O I
10.1016/j.jfma.2020.07.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in North America and Europe, with increasing prevalence in other regions of the world. Its spectrum encompass steatosis, non-alcoholic steatohepatitis (NASH), fibrosis and cirrhosis. It is considered as the manifestation of metabolic syndrome in liver, and its development and progression is influenced by complex interaction of environmental and genetic factors. In this review we discuss the histopathological features, differential diagnoses, and the commonly used grading and staging systems of NAFLD. NAFLD associated with other diseases, histological changes after therapeutic intervention and recurrence or occurrence of NAFLD after liver transplantation are also addressed. Copyright (C) 2020, Formosan Medical Association. Published by Elsevier Taiwan LLC.
引用
收藏
页码:68 / 77
页数:10
相关论文
共 50 条
  • [21] Non-alcoholic fatty liver disease and childhood obesity
    Mathur, Prashant
    Das, Manoja K.
    Arora, Narendra K.
    INDIAN JOURNAL OF PEDIATRICS, 2007, 74 (04) : 401 - 407
  • [22] Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future
    Araujo, Ana Ruth
    Rosso, Natalia
    Bedogni, Giorgio
    Tiribelli, Claudio
    Bellentani, Stefano
    LIVER INTERNATIONAL, 2018, 38 : 47 - 51
  • [23] Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis
    Polyzos, Stergios A.
    Aronis, Konstantinos N.
    Kountouras, Jannis
    Raptis, Dimitrios D.
    Vasiloglou, Maria F.
    Mantzoros, Christos S.
    DIABETOLOGIA, 2016, 59 (01) : 30 - 43
  • [24] An extended fatty liver index to predict non-alcoholic fatty liver disease
    Kantartzis, K.
    Rettig, I.
    Staiger, H.
    Machann, J.
    Schick, F.
    Scheja, L.
    Gastaldelli, A.
    Bugianesi, E.
    Peter, A.
    Schulze, M. B.
    Fritsche, A.
    Haering, H. -U.
    Stefan, N.
    DIABETES & METABOLISM, 2017, 43 (03) : 229 - 239
  • [25] Correlation of Body Mass Index and Serum Parameters With Ultrasonographic Grade of Fatty Change in Non-alcoholic Fatty Liver Disease
    Abangah, Ghobad
    Yousefi, Atefeh
    Asadollahi, Rouhangiz
    Veisani, Yousef
    Rahimifar, Paria
    Alizadeh, Sajjad
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2014, 16 (01)
  • [26] Familial Mediterranean fever: an association with non-alcoholic fatty liver disease
    Rimar, Doron
    Rosner, Itzhak
    Rozenbaum, Michael
    Zuckerman, Eli
    CLINICAL RHEUMATOLOGY, 2011, 30 (07) : 987 - 991
  • [27] Clinical approaches to non-alcoholic fatty liver disease
    Schwenger, Katherine J. P.
    Allard, Johane P.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (07) : 1712 - 1723
  • [29] Non-alcoholic fatty liver disease:An expanded review
    Mark Benedict
    Xuchen Zhang
    World Journal of Hepatology, 2017, (16) : 715 - 732
  • [30] Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: A clinical and pathological study
    Alexander, Jacob
    Torbenson, Michael
    Wu, Tsung-Teh
    Yeh, Matthew M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (05) : 848 - 854